NR4A1 and obesity due to melanocortin 4 receptor deficiency: Overall, obesity was found to be associated with an increased risk of recurrence and death of approximately 35% to 40% after adjusting for tumor-related variables, regardless of menopausal or hormone receptor status [17–19].